2C0

baclofen

Created:2013-09-19
Last modified:  2020-06-05

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count1
Bond Count26
Aromatic Bond Count6
2D diagram of 2C0

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle HydrogenToggle Labels

Chemical Component Summary

Namebaclofen
Synonyms(3R)-4-amino-3-(4-chlorophenyl)butanoic acid
Systematic Name (OpenEye OEToolkits)(3R)-4-azanyl-3-(4-chlorophenyl)butanoic acid
FormulaC10 H12 Cl N O2
Molecular Weight213.661
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01Clc1ccc(cc1)C(CN)CC(=O)O
SMILESCACTVS3.385NC[CH](CC(O)=O)c1ccc(Cl)cc1
SMILESOpenEye OEToolkits1.7.6c1cc(ccc1C(CC(=O)O)CN)Cl
Canonical SMILESCACTVS3.385 NC[C@H](CC(O)=O)c1ccc(Cl)cc1
Canonical SMILESOpenEye OEToolkits1.7.6 c1cc(ccc1[C@@H](CC(=O)O)CN)Cl
InChIInChI1.03 InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1
InChIKeyInChI1.03 KPYSYYIEGFHWSV-QMMMGPOBSA-N

Drug Info: DrugBank

DrugBank IDDB08891 
NameArbaclofen
Groups investigational
DescriptionArbaclofen, or STX209, is the R-enantiomer of baclofen. It is believed to be a selective gamma-amino butyric acid type B receptor agonist, and has been investigated as a treatment for autism spectrum disorder and fragile X syndrome in randomized, double blind, placebo controlled trials. It has also been investigated as a treatment for spasticity due to multiple sclerosis and spinal cord injury. Arbaclofen was investigated as a treatment for gastroesophageal reflux disease (GERD); however, with disappointing results.
Synonyms
  • Arbaclofen
  • (R)-4-amino-3-(4-chlorophenyl)butan­oic acid
  • (R)-Baclofen
IndicationInvestigated in clinical trials as a potential treatment for spasticity in multiple sclerosis, autism spectrum disorder, and social withdrawal in fragile X syndrome.
CAS number69308-37-8

Drug Targets

NameTarget SequencePharmacological ActionActions
Gamma-aminobutyric acid type B receptor subunit 1MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQ...unknownagonist
Gamma-aminobutyric acid type B receptor subunit 2MASPRSSGQPGPPPPPPPPPARLLLLLLLPLLLPLAPGAWGWARGAPRPP...unknownagonist
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL301742
PubChem 6918881, 44602
ChEMBL CHEMBL301742
CCDC/CSD WONSIE, CRBMZC10, WONSIE01, LUSXII01, LUSXII, LUSXOO, YIPLAN, LUSXEE, RUWGOG, AQEKUE, LABKAE, LABKEI, LABJUX, LABJIL, FESCUF, FESDAM, FESDEQ
COD 4510988, 4501801